Načítá se...
PELP1: A novel therapeutic target for hormonal cancers
Recent studies implicate the estrogen receptor (ER) coregulator proline-, glutamic acid-, and leucine-rich protein (PELP) 1 as playing critical roles in ER-genomic, ER-nongenomic and ER-signaling cross talk with growth factor signaling pathways. PELP1 expression is deregulated in hormonal cancers an...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2997573/ https://ncbi.nlm.nih.gov/pubmed/20014005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/iub.287 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|